Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Artivion Inc (AORT)

Artivion Inc (AORT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 553,136
  • Shares Outstanding, K 40,316
  • Annual Sales, $ 298,840 K
  • Annual Income, $ -14,830 K
  • 60-Month Beta 1.32
  • Price/Sales 1.80
  • Price/Cash Flow 18.13
  • Price/Book 1.91
Trade AORT with:

Options Overview Details

View History
  • Implied Volatility 82.32% ( -14.46%)
  • Historical Volatility 100.47%
  • IV Percentile 87%
  • IV Rank 57.19%
  • IV High 111.25% on 01/28/22
  • IV Low 43.66% on 04/08/22
  • Put/Call Vol Ratio 2.10
  • Today's Volume 217
  • Volume Avg (30-Day) 72
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 1,977
  • Open Int (30-Day) 1,581

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.10
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.12
  • Prior Year 0.26
  • Growth Rate Est. (year over year) -138.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.90 +8.99%
on 09/23/22
22.45 -37.37%
on 09/12/22
-7.89 (-35.95%)
since 08/26/22
3-Month
12.90 +8.99%
on 09/23/22
23.43 -39.99%
on 08/16/22
-5.24 (-27.15%)
since 06/27/22
52-Week
12.90 +8.99%
on 09/23/22
23.43 -39.99%
on 08/16/22
-9.34 (-39.91%)
since 09/27/21

Most Recent Stories

More News
Artivion Follows Recommendation to Stop PROACT Xa Clinical Trial

/PRNewswire/ --- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has stopped the...

AORT : 14.06 (+2.48%)
Artivion to Present at the Deutsche Bank 30th Annual Leveraged Finance Conference

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present at...

AORT : 14.06 (+2.48%)
Artivion to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...

AORT : 14.06 (+2.48%)
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present...

AORT : 14.06 (+2.48%)
KORU Medical Systems Inc. (KRMD) Reports Q2 Loss, Tops Revenue Estimates

KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of 0% and 4.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

KRMD : 2.33 (+1.75%)
AORT : 14.06 (+2.48%)
Artivion to Participate in Upcoming Investor Conferences

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate...

AORT : 14.06 (+2.48%)
What Makes Artivion (AORT) a New Buy Stock

Artivion (AORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AORT : 14.06 (+2.48%)
Artivion Initiates Enrollment in PERSEVERE Clinical Trial

/PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has initiated...

AORT : 14.06 (+2.48%)
Morgan Stanley Keeps Their Hold Rating on Artivion (AORT)

In a report released today, Cecilia Furlong from Morgan Stanley maintained a Hold rating on Artivion (AORT – Research Report), with a price target of $21.00. The company's shares closed last Friday at...

AORT : 14.06 (+2.48%)
Artivion (AORT) Soars 10.2%: Is Further Upside Left in the Stock?

Artivion (AORT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in...

AORT : 14.06 (+2.48%)
IART : 42.28 (-1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Artivion Inc. is a medical device company. It focused on developing simple, elegant solutions which address cardiac and vascular surgeons. The company's group of products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts and surgical sealants....

See More

Key Turning Points

3rd Resistance Point 15.26
2nd Resistance Point 14.85
1st Resistance Point 14.45
Last Price 14.06
1st Support Level 13.64
2nd Support Level 13.23
3rd Support Level 12.83

See More

52-Week High 23.43
Fibonacci 61.8% 19.41
Fibonacci 50% 18.17
Fibonacci 38.2% 16.92
Last Price 14.06
52-Week Low 12.90

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar